CliffBio
small molecule

CLENPIQ

CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE

Loss of exclusivityJanuary 2038latest FDA-listed patent expiry
CompanyFerring Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameCLENPIQ
Active ingredientCITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
Strength12GM/BOT;3.5GM/BOT;10MG/BOT
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2017
Marketing statusRX

Listed patents

PatentExpiresType
12458634January 2038product
9827231June 2034product
11191753June 2034use U-3261
12576072June 2034product
10624879June 2034product

More from Ferring Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

CLENPIQ patent cliff — loss of exclusivity January 2038 | CliffBio